Zobrazeno 1 - 10
of 4 039
pro vyhledávání: '"Sebag M"'
Autor:
Tanguay M; Institut universitaire d'hémato-oncologie et de thérapie cellulaire, Hôpital Maisonneuve-Rosemont, Montréal, Québec, Canada.; Université de Montréal, Montréal, Québec, Canada., Roy J; Institut universitaire d'hémato-oncologie et de thérapie cellulaire, Hôpital Maisonneuve-Rosemont, Montréal, Québec, Canada.; Université de Montréal, Montréal, Québec, Canada., Su J; Canadian Myeloma Research Group, Vaughan, Ontario, Canada., Gul E; Canadian Myeloma Research Group, Vaughan, Ontario, Canada., Reece D; Canadian Myeloma Research Group, Vaughan, Ontario, Canada.; Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Venner CP; BC Cancer - Vancouver Centre, University of British Columbia, Vancouver, British Columbia, Canada., White D; Queen Elizabeth II Health Sciences Centre, Dalhousie University, Halifax, Nova Scotia, Canada., Chu MP; Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada., Jimenez-Zepada VH; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, Canada., Song K; BC Cancer Agency, Vancouver General Hospital, Vancouver, British Columbia, Canada., Mccurdy A; The Ottawa Hospital, Ottawa, Ontario, Canada., Mian H; Juravinski Cancer Center, Hamilton, Ontario, Canada., Sebag M; Department of Medicine, McGill University, Montréal, Québec, Canada., Bergstrom D; Memorial University of Newfoundland, St John's, Newfoundland and Labrador, Canada., Stakiw J; Saskatoon Cancer Centre, University of Saskatchewan, Saskatoon, Saskatchewan, Canada., Reiman A; Department of Oncology, Saint John Regional Hospital, Saint John, New Brunswick, Canada., Kotb R; Cancer Care Manitoba, Winnipeg, Manitoba, Canada., Aslam M; Allan Blair Cancer Centre, Regina, Saskatchewan, Canada., Kaedbey R; Jewish General Hospital, Montréal, Québec, Canada., Louzada M; London Regional Cancer Center, London, Ontario, Canada., LeBlanc R; Institut universitaire d'hémato-oncologie et de thérapie cellulaire, Hôpital Maisonneuve-Rosemont, Montréal, Québec, Canada.; Université de Montréal, Montréal, Québec, Canada.
Publikováno v:
Cancer medicine [Cancer Med] 2024 Nov; Vol. 13 (21), pp. e70332.
Autor:
Bhella S; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto ON, Canada. Electronic address: sita.bhella@uhn.ca., Wilkin AM; Ottawa Hospital Research Institute, Ottawa ON, Canada., Hueniken K; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto ON, Canada., Vijenthira A; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto ON, Canada., Sebag M; McGill University Health Centre, Montreal, QC, Canada., Wang P; Department of Medicine, University of Alberta, Edmonton, AB, Canada., Hicks LK; Division of Hematology/Oncology, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada., Hay AE; Queen's University, Kingston, ON, Canada., Assouline S; Jewish General Hospital, Montreal, QC, Canada., Fraser G; Department of Oncology, McMaster University, Hamilton, ON, Canada., Balitsky A; Department of Oncology, McMaster University, Hamilton, ON, Canada., Mangel J; Division of Hematology, Department of Medicine, Schulich School of Medicine & Dentistry, London, ON, Canada., Owen C; University of Calgary, Tom Baker Cancer Centre, Division of Hematology and Hematological Malignancies, Calgary, AB, Canada., Reiman A; Department of Oncology, Saint John Regional Hospital, Saint John, NB, Canada., Sehn L; BC Cancer Centre for Lymphoma Cancer, University of British Columbia, Vancouver, BC, Canada., Sutherland H; Leukemia/Bone Marrow Transplant Program of British Columbia, Vancouver General Hospital, BC Cancer, University of British Columbia, Vancouver, BC, Canada., Zhang T; Ottawa Hospital Research Institute, Ottawa ON, Canada., Arnold C; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada., Leite T; Ottawa Hospital Research Institute, Ottawa ON, Canada., McCarthy E; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto ON, Canada., Cooper C; Ottawa Hospital Research Institute, Ottawa ON, Canada., Langlois MA; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada., Arianne Buchan C; Ottawa Hospital Research Institute, Ottawa ON, Canada.
Publikováno v:
Vaccine [Vaccine] 2024 Oct 24; Vol. 42 (24), pp. 126074. Date of Electronic Publication: 2024 Jun 28.
Autor:
Venner CP; BC Cancer, Vancouver Centre, Vancouver, British Columbia, Canada. Electronic address: christopher.venner@bccancer.bc.ca., Duggan P; Department of Hematology, Tom Baker Cancer Center, University of Calgary, Calgary, Alberta, Canada., Song K; BC Cancer Agency, University of British Columbia, Vancouver, British Columbia, Canada., Reece D; Princess Margaret Cancer Centre, Toronto, Ontario, Canada; Canadian Myeloma Research Group, Vaughan, Ontario, Canada., Sharma S; Canadian Myeloma Research Group, Vaughan, Ontario, Canada., Su J; Canadian Myeloma Research Group, Vaughan, Ontario, Canada., Jimenez-Zepeda VH; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, Canada., McCurdy A; The Ottawa Hospital, Ottawa, Ontario, Canada., Louzada M; London Regional Cancer Center, London, Ontario, Canada., Mian H; Juravinski Cancer Center, Hamilton, Ontario, Canada., Sebag M; McGill University, Montreal, Quebec, Canada., White D; Queen Elizabeth II Health Sciences Centre. Dalhousie University, Halifax, Nova Scotia, Canada., Stakiw J; Saskatoon Cancer Centre, University of Saskatchewan, Saskatoon, Saskatchewan, Canada., Kotb R; Cancer Care Manitoba, Winnipeg, Manitoba, Canada., Aslam M; Allan Blair Cancer Centre, Regina, Saskatchewan, Canada., Reiman A; Saint John Regional Hospital, Saint John, New Brunswick, Canada., Gul E; Canadian Myeloma Research Group, Vaughan, Ontario, Canada., Chu MP; Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada., Bergstrom D; Division of Hematology, Memorial University of Newfoundland, St John's, Newfoundland and Labrador, St John's, Newfoundland, Canada., LeBlanc R; Maisonneuve-Rosemont Hospital Research Centre, University of Montreal, Montreal, Quebec, Canada.
Publikováno v:
Transplantation and cellular therapy [Transplant Cell Ther] 2024 Sep; Vol. 30 (9), pp. 889-901. Date of Electronic Publication: 2024 Jul 04.
Autor:
Bahlis NJ; University of Calgary, Calgary, AB, Canada., Samaras C; Cleveland Clinic, Cleveland, OH., Reece D; Princess Margaret Hospital, Toronto, ON, Canada., Sebag M; McGill University Health Centre, Montreal, QC, Canada., Matous J; Colorado Blood Cancer Institute, Sarah Cannon Research Institute, Denver, CO., Berdeja JG; Sarah Cannon Cancer Center, Nashville, TN., Shustik J; BC Cancer, Surrey Centre, Surrey, BC, Canada., Schiller GJ; David Geffen School of Medicine at UCLA, Los Angeles, CA., Ganguly S; Houston Methodist Hospital Neal Cancer Center, Houston, TX., Song K; Vancouver General Hospital, Vancouver, BC, Canada., Seet CS; UCLA Medical Center, Los Angeles, CA., Acosta-Rivera M; Fundación de Investigación de Diego, San Juan, PR., Bar M; Stamford Hospital, Stamford, CT., Quick D; Joe Arrington Cancer Research and Treatment Center, Lubbock, TX., Fonseca G; Florida Cancer Specialists, Lecanto, FL., Liu H; Bristol Myers Squibb, Princeton, NJ., Gentili C; Bristol Myers Squibb, Boudry, Switzerland., Singh P; Bristol Myers Squibb, Princeton, NJ., Siegel D; John Theurer Cancer Center, Hackensack, NJ. Electronic address: davids.siegel@hmhn.org.
Publikováno v:
Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2024 Aug 08. Date of Electronic Publication: 2024 Aug 08.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Population (French Edition), 1961 Oct 01. 16(4), 770-771.
Externí odkaz:
https://www.jstor.org/stable/1526639
Publikováno v:
In Signal Processing January 2017 130:389-402
Autor:
Kaedbey R; Division of Hematology, Department of Medicine Jewish General Hospital Montreal Canada., Reece D; Department of Medical Oncology and Hematology Princess Margaret Cancer Centre Toronto Canada.; Canadian Myeloma Research Group Vaughan Canada., Venner CP; Department of Hematology Lymphoma and Myeloma Program, BC Cancer, Vancouver Centre Vancouver Canada., McCurdy A; Department of Medicine The Ottawa Hospital Ottawa Canada., Su J; Canadian Myeloma Research Group Vaughan Canada., Chu M; Department of Medicine Cross Cancer Institute Edmonton Canada., Louzada M; Department of Medicine London Regional Cancer Center London Canada., Jimenez-Zepeda VH; Department of Medicine Arnie Charbonneau Cancer Institute, University of Calgary Calgary Canada., Mian H; Department of Medicine Juravinski Cancer Center Hamilton Canada., Song K; Department of Medicine BC Cancer Agency, Vancouver General Hospital Vancouver Canada., Sebag M; Department of Medicine McGill University Montreal Canada., Stakiw J; Department of Medicine Saskatoon Cancer Centre, University of Saskatchewan Saskatoon Canada., White D; Division of Hematology Queen Elizabeth II Health Sciences Centre. Dalhousie University Halifax Canada., Reiman A; Department of Medicine Saint John Regional Hospital Saint John Canada., Aslam M; Department of Medical Oncology Allan Blair Cancer Centre Regina Canada., Kotb R; Department of Medical Oncology & Hematology Cancer Care Manitoba Winnipeg Canada., Bergstrom D; Division of Hematology Memorial University of Newfoundland St John's Canada., Gul E; Canadian Myeloma Research Group Vaughan Canada., LeBlanc R; Department of Medical Oncology Maisonneuve-Rosemont Hospital Research Centre, University of Montreal Montreal Canada.
Publikováno v:
EJHaem [EJHaem] 2024 Apr 29; Vol. 5 (3), pp. 474-484. Date of Electronic Publication: 2024 Apr 29 (Print Publication: 2024).
Publikováno v:
Actes de la 9ème Conférence Nationale sur les Applications Pratiques de l’Intelligence Artificielle (APIA) PFIA 2023
9ème Conférence Nationale sur les Applications Pratiques de l’Intelligence Artificielle APIA@PFIA2023
9ème Conférence Nationale sur les Applications Pratiques de l’Intelligence Artificielle APIA@PFIA2023, AFIA-Association Française pour l'Intelligence Artificielle; ICube-laboratoire des sciences de l'ingénieur, de l'informatique et de l'imagerie, Jul 2023, Strasbourg, France. pp.89-98
9ème Conférence Nationale sur les Applications Pratiques de l’Intelligence Artificielle APIA@PFIA2023
9ème Conférence Nationale sur les Applications Pratiques de l’Intelligence Artificielle APIA@PFIA2023, AFIA-Association Française pour l'Intelligence Artificielle; ICube-laboratoire des sciences de l'ingénieur, de l'informatique et de l'imagerie, Jul 2023, Strasbourg, France. pp.89-98
National audience; The matching setting, a particular case of recommendation problem, focuses on applications where a so-called item can be attributed to at most one user, with the job market and the matrimonial market as chief examples. In such case
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______165::ce6959da0f0c5ac1c6802ca78899bd28
https://hal.science/hal-04158566/document
https://hal.science/hal-04158566/document
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.